These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 4581340)

  • 81. Fifty Years of Expert Advice - Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study.
    Schwartz JL
    N Engl J Med; 2016 Nov; 375(21):2015-2017. PubMed ID: 27959733
    [No Abstract]   [Full Text] [Related]  

  • 82. Exempt preparations: Historical perspectives.
    Harris LS
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S48-51. PubMed ID: 16529881
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Restricting the sale of "deadly poisons". Pharmacists, drug regulation, and narratives of suffering in the Gilded Age.
    Gabriel JM
    Pharm Hist; 2011; 53(1):29-45. PubMed ID: 22702023
    [No Abstract]   [Full Text] [Related]  

  • 84. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).
    Doshi A
    Seton Hall Law Rev; 2007; 37(2):625-60. PubMed ID: 17294569
    [No Abstract]   [Full Text] [Related]  

  • 85. The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?
    Shulman SR; Brown JS
    Food Drug Law J; 1995; 50(4):503-31. PubMed ID: 10343017
    [No Abstract]   [Full Text] [Related]  

  • 86. Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration.
    Oram M
    Hist Psychiatry; 2016 Sep; 27(3):290-306. PubMed ID: 27194113
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Government regulations and the use of drugs.
    Hafkenschiel JH
    Calif Med; 1967 Aug; 107(2):159-63. PubMed ID: 4862066
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pharmacy ...and the Food and Drug Law.
    Janssen WF
    Am Pharm; 1981 Apr; NS21(4):28-36. PubMed ID: 7013459
    [No Abstract]   [Full Text] [Related]  

  • 89. Drugs and the Washington climate.
    Durant TM
    Trans Am Clin Climatol Assoc; 1969; 80():196-204. PubMed ID: 4896316
    [No Abstract]   [Full Text] [Related]  

  • 90. Your health in the 21st century. A better safety net.
    Rosenberg D
    Newsweek; 2005; 145(26A):70-2. PubMed ID: 16375152
    [No Abstract]   [Full Text] [Related]  

  • 91. [Drug industry in France: some historical points].
    Sigvard J
    Bull Acad Natl Med; 1982 Jun; 166(6):829-34. PubMed ID: 6756598
    [No Abstract]   [Full Text] [Related]  

  • 92. Investigations and reports respecting FDA regulation of new drugs (Part I).
    Hutt PB
    Clin Pharmacol Ther; 1983 Apr; 33(4):537-48. PubMed ID: 6339149
    [No Abstract]   [Full Text] [Related]  

  • 93. The Evolution of Federal Regulation of Human Drugs in the United States: An Historical Essay.
    Hutt PB
    Am J Law Med; 2018 May; 44(2-3):403-451. PubMed ID: 30106657
    [No Abstract]   [Full Text] [Related]  

  • 94. New drugs-miracles or mirages?
    JAMA; 2014 Jan 22-29; 311(4):423. PubMed ID: 24449329
    [No Abstract]   [Full Text] [Related]  

  • 95. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 96. Investigations and reports respecting FDA regulation of new drugs (Part II).
    Hutt PB
    Clin Pharmacol Ther; 1983 May; 33(5):674-87. PubMed ID: 6340910
    [No Abstract]   [Full Text] [Related]  

  • 97. Criminal laws and the control of drugs of abuse. An historical view of the law (or, it's the lawyer's fault).
    Hollister LE
    J Clin Pharmacol J New Drugs; 1969; 9(6):345-8. PubMed ID: 4900515
    [No Abstract]   [Full Text] [Related]  

  • 98. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances.
    Joranson DE
    NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529
    [No Abstract]   [Full Text] [Related]  

  • 99. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
    Heymann LA
    Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
    [No Abstract]   [Full Text] [Related]  

  • 100. Review of the processes for FDA oversight of drugs, medical devices, and combination products.
    Sweet BV; Schwemm AK; Parsons DM
    J Manag Care Pharm; 2011; 17(1):40-50. PubMed ID: 21204589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.